Barbara Pro

17.4k citations
293 papers · 10.4k · 4 hit papers · h-index 48

Impact in

Papers in

Barbara Pro

285 papers receiving 10.2k citations

Barbara Pro's Hit Papers

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study 2012 · 754 citations
7540+5+11Years since publication250500750

Peers

Barbara Pro
Comparison fields: 5 of 114
  • Pathology and Forensic Medicine 6.6k
  • Genetics 2.0k
  • Oncology 4.6k
  • Dermatology 1.5k
  • Immunology 2.1k
Replace German Ott with:
German Ott Germany
Won Seog Kim South Korea
Jorge Romaguera United States
Luis Fayad United States
Armando López‐Guillermo Spain
Eric D. Hsi United States
Elisabeth Ralfkiær Denmark
Kerry J. Savage Canada
Hans Hagberg Sweden
Fredrick B. Hagemeister United States
Barbara Pro relative to German Ott Germany German Ott's profile →
Citations per field
00.5×1.6×
German Ott · 1×
Citations per year

Countries citing papers authored by Barbara Pro

Since Specialization
Citations

This map shows the geographic impact of Barbara Pro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Pro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Pro more than expected).

Fields of papers citing papers by Barbara Pro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Pro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Pro. The network helps show where Barbara Pro may publish in the future.

Co-authors

The 25 scholars most cited alongside Barbara Pro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Pro Line = papers co-authored together Barbara Pro links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 293 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Hit paper breakdown →
2012754
2
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
Hit paper breakdown →
2009543
3
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Hit paper breakdown →
2012514
4
Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
Hit paper breakdown →
2011454
5 2004436
6 2013400
7 2005400
8 2004373
9 2003211
10 2003180
11 2010175
12 2017172
13 2010167
14 2003164
15 2014153
16 2006152
17 2009139
18 2014128
19 2017115
20 2007113

About Barbara Pro

Barbara Pro is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Dermatology, having authored 293 papers that have together received 10.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (218 papers), Chronic Lymphocytic Leukemia Research (78 papers), Cutaneous lymphoproliferative disorders research (45 papers), T-cell and Retrovirus Studies (42 papers), Viral-associated cancers and disorders (40 papers), CAR-T cell therapy research (38 papers), CNS Lymphoma Diagnosis and Treatment (22 papers) and Histone Deacetylase Inhibitors Research (22 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.6k citations), Genetics (2.0k citations), Oncology (4.6k citations), Dermatology (1.5k citations) and Immunology (2.1k citations). Barbara Pro has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Peter McLaughlin, Luis Fayad, Anas Younes, Jorge Romaguera, Andrei R. Shustov, Felipe Samaniego, Maria Alma Rodriguez, André Goy, Nam H. Dang and Fernando Cabanillas. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Cancer and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact